{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:22:50Z","timestamp":1785892970236,"version":"3.56.0"},"reference-count":23,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2021,1,30]]},"DOI":"10.1536\/ihj.20-479","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T22:13:27Z","timestamp":1611958407000},"page":"135-141","source":"Crossref","is-referenced-by-count":4,"title":["Prediction of Serious Adverse Events of Patients with Hypertrophic Cardiomyopathy by Magnetic Resonance"],"prefix":"10.1536","volume":"62","author":[{"given":"Jin","family":"Komuro","sequence":"first","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine"},{"name":"Department of Cardiology, Sakakibara Heart Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Iguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sakakibara Heart Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Utanohara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sakakibara Heart Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morimasa","family":"Takayama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sakakibara Heart Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Umemura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sakakibara Heart Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitonobu","family":"Tomoike","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sakakibara Heart Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Richardson P, McKenna W, Bristow M, <i>et al<\/i>. Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93: 841-2.","DOI":"10.1161\/01.CIR.93.5.841"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ko T. Left atrium as an active component of the pathophysiology in HCM. Int Heart J 2018; 59: 906-8.","DOI":"10.1536\/ihj.18-441"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000; 342: 1778-85.","DOI":"10.1056\/NEJM200006153422403"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Elliott PM, Gimeno Blanes JR, Mahon NG, Poloniecki JD, McKenna WJ. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 2001; 357: 420-4.","DOI":"10.1016\/S0140-6736(00)04005-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Geske JB, Ommen SR, Gersh BJ. Hypertrophic cardiomyopathy: Clinical update. JACC Heart Fail 2018; 6: 364-75.","DOI":"10.1016\/j.jchf.2018.02.010"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural ( &apos;small vessel&apos;) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986; 8: 545-57.","DOI":"10.1016\/S0735-1097(86)80181-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003; 349: 1027-35.","DOI":"10.1056\/NEJMoa025050"},{"key":"8","unstructured":"8. Dilsizian V, Taillefer R. Journey in evolution of nuclear cardiology: Will there be another quantum leap with the F-18-labeled myocardial perfusion tracers? JACC Cardiovasc Imaging 2012; 5: 1269-84."},{"key":"9","unstructured":"9. Camici PG, Cecchi F, Gistri R, <i>et al<\/i>. Dipyridamole-induced subendocardial underperfusion in hypertrophic cardiomyopathy assessed by positron-emission tomography. Coron Artery Dis 1991; 2: 837-84."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nagueh SF, Zoghbi WA. Role of imaging in the evaluation of patients at risk for sudden cardiac death: Genotype-phenotype intersection. JACC Cardiovasc Imaging 2015; 8: 828-45.","DOI":"10.1016\/j.jcmg.2015.04.006"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yin L, Xu HY, Zheng SS, <i>et al<\/i>. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy. Int J Cardiovasc Imaging 2017; 33: 1949-59.","DOI":"10.1007\/s10554-017-1189-9"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Knaapen P, Germans T, Camici PG, <i>et al<\/i>. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 2008; 294: H986-93.","DOI":"10.1152\/ajpheart.00233.2007"},{"key":"13","unstructured":"13. Torizuka K, Yonekura Y, Nishimura T, <i>et al<\/i>. A Phase 1 study of beta-methyl-<i>p<\/i>- (123I) -iodophenyl-pentadecanoic acid (123I-BMIPP). Kaku igaku 1991; 28: 681-90."},{"key":"14","unstructured":"14. Torizuka K, Yonekura Y, Nishimura T, Tamaki N, Uehara T. Phase 2 study of beta-methyl-<i>p<\/i>- (123I) -iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating myocardial fatty acid metabolism. Kaku igaku 1992; 29: 305-17."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tamaki N, Yoshinaga K. Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology. J Nucl Cardiol 2011; 18: 135-43.","DOI":"10.1007\/s12350-010-9305-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Momose M, Fukushima K, Kondo C, <i>et al<\/i>. Diagnosis and detection of myocardial injury in active cardiac sarcoidosis - Significance of myocardial fatty acid metabolism and myocardial perfusion mismatch. Circ J 2015; 79: 2669-76.","DOI":"10.1253\/circj.CJ-15-0681"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Abe H, Iguchi N, Utanohara Y, <i>et al<\/i>. Non-invasive diagnosis of coronary artery disease by <sup>123<\/sup>I-BMIPP\/<sup>201<\/sup>TlCl dual myocardial SPECT in patients with heart failure. Int J Cardiol 2014; 176: 969-74.","DOI":"10.1016\/j.ijcard.2014.08.129"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Bietenbeck M, Florian A, Shomanova Z, Meier C, Yilmaz A. Reduced global myocardial perfusion reserve in DCM and HCM patients assessed by CMR-based velocity-encoded coronary sinus flow measurements and first-pass perfusion imaging. Clin Res Cardiol 2018; 107: 1062-70.","DOI":"10.1007\/s00392-018-1279-2"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Mavrogeni S, Petrou E, Kolovou G, Theodorakis G, Iliodromitis E. Prediction of ventricular arrhythmias using cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging 2013; 14: 518-25.","DOI":"10.1093\/ehjci\/jes302"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Huang L, Han R, Ai T, <i>et al<\/i>. Assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy: First-pass myocardial perfusion cardiovascular magnetic resonance imaging at 1.5 T. Clin Radiol 2013; 68: 676-82.","DOI":"10.1016\/j.crad.2013.01.003"},{"key":"21","unstructured":"21. Salerno M. Inline quantitative myocardial perfusion by CMR: Coming online soon? JACC Cardiovasc Imaging 2019; 12: 1970-2."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Gibson CM, Pride YB, Buros JL, <i>et al<\/i>; for the TIMI Study Group. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction. J Am Coll Cardiol 2008; 51: 546-51.","DOI":"10.1016\/j.jacc.2007.08.061"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Stevenson WG, Friedman PL, Sager PT, <i>et al<\/i>. Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping. J Am Coll Cardiol 1997; 29: 1180-9.","DOI":"10.1016\/S0735-1097(97)00065-X"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/1\/62_20-479\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T03:58:45Z","timestamp":1611979125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/1\/62_20-479\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,30]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-479","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,30]]}}}